162 related articles for article (PubMed ID: 15272147)
1. APP, NGF & the 'Sunday-driver' in a Trolley on the Road.
Heese K; Inoue N; Nagai Y; Sawada T
Restor Neurol Neurosci; 2004; 22(2):131-6. PubMed ID: 15272147
[TBL] [Abstract][Full Text] [Related]
2. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
3. The cholinergic system, nerve growth factor and the cytoskeleton.
Niewiadomska G; Mietelska-Porowska A; Mazurkiewicz M
Behav Brain Res; 2011 Aug; 221(2):515-26. PubMed ID: 20170684
[TBL] [Abstract][Full Text] [Related]
4. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
[TBL] [Abstract][Full Text] [Related]
5. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.
Canu N; Amadoro G; Triaca V; Latina V; Sposato V; Corsetti V; Severini C; Ciotti MT; Calissano P
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632177
[TBL] [Abstract][Full Text] [Related]
6. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
Triaca V; Ruberti F; Canu N
Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease.
Lad SP; Neet KE; Mufson EJ
Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):315-34. PubMed ID: 14529363
[TBL] [Abstract][Full Text] [Related]
8. Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons.
Sáez ET; Pehar M; Vargas MR; Barbeito L; Maccioni RB
J Neurosci Res; 2006 Oct; 84(5):1098-106. PubMed ID: 16862561
[TBL] [Abstract][Full Text] [Related]
9. Does the term 'trophic' actually mean anti-amyloidogenic? The case of NGF.
Calissano P; Amadoro G; Matrone C; Ciafrè S; Marolda R; Corsetti V; Ciotti MT; Mercanti D; Di Luzio A; Severini C; Provenzano C; Canu N
Cell Death Differ; 2010 Jul; 17(7):1126-33. PubMed ID: 20395961
[TBL] [Abstract][Full Text] [Related]
10. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
[TBL] [Abstract][Full Text] [Related]
12. TrkA pathway activation induced by amyloid-beta (Abeta).
Bulbarelli A; Lonati E; Cazzaniga E; Re F; Sesana S; Barisani D; Sancini G; Mutoh T; Masserini M
Mol Cell Neurosci; 2009 Mar; 40(3):365-73. PubMed ID: 19162192
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
[TBL] [Abstract][Full Text] [Related]
14. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
Suzuki T; Araki Y; Yamamoto T; Nakaya T
J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
[TBL] [Abstract][Full Text] [Related]
15. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
Koistinaho M; Koistinaho J
Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
[TBL] [Abstract][Full Text] [Related]
16. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibitors modulate nerve growth factor-mediated regulation of amyloid precursor protein expression in PC12 cells.
Binnington JC; Kalisch BE
J Neurochem; 2007 Apr; 101(2):422-33. PubMed ID: 17402971
[TBL] [Abstract][Full Text] [Related]
18. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.
Fahnestock M; Michalski B; Xu B; Coughlin MD
Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181
[TBL] [Abstract][Full Text] [Related]
19. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
[TBL] [Abstract][Full Text] [Related]
20. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]